Production (Stage)
Protagenic Therapeutics, Inc.
PTIX
$3.62
$0.1353.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -52.52% | 74.13% | 14.19% | -61.85% | -40.24% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 24.32% | -87.90% | -17.42% | 909.77% | -69.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -50.70% | 32.35% | 3.93% | -44.53% | -41.24% |
|
|
|||||
| Total Current Assets | -50.70% | 32.35% | 3.93% | -44.53% | -41.24% |
| Net Property, Plant & Equipment | -17.12% | -14.72% | -12.83% | -11.37% | -10.14% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -49.45% | 29.68% | 2.81% | -43.10% | -40.36% |
|
|
|||||
| Total Accounts Payable | 60.39% | -5.16% | 16.15% | -14.22% | -4.22% |
| Total Accrued Expenses | 8.56% | 23.37% | 17.14% | 72.38% | -37.75% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 14.23% | 19.45% | 17.00% | 51.22% | -31.92% |
|
|
|||||
| Total Current Liabilities | 14.23% | 19.45% | 17.00% | 51.22% | -31.92% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.23% | 19.45% | 17.00% | 51.22% | -31.92% |
|
|
|||||
| Common Stock & APIC | 0.90% | 5.19% | 1.62% | 0.89% | 0.47% |
| Retained Earnings | -3.97% | -4.47% | -1.88% | -4.94% | -5.60% |
| Treasury Stock & Other | 0.00% | 0.23% | 0.00% | -50.00% | 23.52% |
| Total Common Equity | -108.71% | 40.92% | -9.27% | -62.84% | -41.86% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -108.71% | 40.92% | -9.27% | -62.84% | -41.86% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -108.71% | 40.92% | -9.27% | -62.84% | -41.86% |
|
|
|||||